Comparison of three methods for identifying medical drug-psychotropic drug interactions

被引:4
|
作者
Strain, JJ [1 ]
Chiu, NM
Brodsky, M
Karim, A
Caliendo, G
机构
[1] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA
[2] Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan
[3] Mt Sinai NYU Med Ctr Hlth Syst, Dept Neurol, Mt Sinai Sch Med, New York, NY 10029 USA
[4] Mt Sinai Hosp, Dept Pharm, New York, NY 10029 USA
关键词
D O I
10.1016/S0163-8343(02)00196-2
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Three methods for examining drug-drug interactions were compared to understand advantages and disadvantages of each: ePocrates; Interact; The Mount Sinai multiple source for the evaluation of drug-drug interactions (MS). ePocrates is a commonly employed software system utilized in a hand held computer, the PalmPilot. Interact is on a CD-ROM, and promoted by the American Psychiatric Association Press. The MS system was developed by the authors and utilizes six separate references sources to ascertain the presence and significance of drug-drug interactions. Commonly prescribed neurology and psychotropic medication interactions were compared using the three systems. ePocrates did not list the significance level of the interaction, e.g., (major, moderate, minor), often did not include a mechanism of action, and several commonly employed medications were not included. It did permit examining several drugs at the same time, and was easily carried on the person of the physician. Interact often contained old references, several drugs were not included, was not adapted to a hand held computer format, and had no update since 1999. The MS system listed level of significance, provided mechanism of action, and advice to the practitioner including recommendations. It is not portable, requiring a laptop or desk top computer or hard copy, and only searches one drug at a time. It is hoped that the advantages of each of these three systems may be incorporated into systems of the future. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:311 / 315
页数:5
相关论文
共 50 条
  • [1] Update: Drug-psychotropic drug interactions
    Strain, JJ
    Caliendo, G
    Himelein, C
    GENERAL HOSPITAL PSYCHIATRY, 1997, 19 (06) : 429 - 431
  • [2] Neurologic drug-psychotropic drug update
    Strain, JJ
    Karim, A
    Caliendo, G
    Brodsky, M
    Lowe, RS
    Himelein, C
    GENERAL HOSPITAL PSYCHIATRY, 2002, 24 (05) : 290 - 310
  • [3] Cardiac drug-psychotropic drug update
    Strain, JJ
    Karim, A
    Caliendo, G
    Alexis, JD
    Lowe, RS
    Fuster, V
    GENERAL HOSPITAL PSYCHIATRY, 2002, 24 (05) : 283 - 289
  • [4] PSYCHOTROPIC AND MEDICAL DRUG-INTERACTIONS
    ANANTH, J
    JOHNSON, K
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 1992, 58 (3-4) : 178 - 196
  • [5] Psychotropic Drug-Drug Interactions in Three Most Commonly Used Drug Information Databases
    Liu, Xinyue
    Barnicoat, Marie
    Bussing, Regina
    Winterstein, Almut G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 452 - 453
  • [6] An overview of psychotropic drug-drug interactions
    Sandson, NB
    Armstrong, SC
    Cozza, KL
    PSYCHOSOMATICS, 2005, 46 (05) : 464 - 494
  • [7] PSYCHOTROPIC-DRUG INTERACTIONS
    WATSKY, EJ
    SALZMAN, C
    HOSPITAL AND COMMUNITY PSYCHIATRY, 1991, 42 (03): : 247 - 256
  • [8] Cytochromes and psychotropic drug interactions
    Taylor, D
    Lader, M
    BRITISH JOURNAL OF PSYCHIATRY, 1996, 168 (05) : 529 - 532
  • [9] Psychotropic drug interactions with valproate
    Fleming, J
    Chetty, M
    CLINICAL NEUROPHARMACOLOGY, 2005, 28 (02) : 96 - 101
  • [10] Valproate and psychotropic drug interactions
    Glen, J.
    Fleming, J.
    Herman, M.
    Chetty, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S401 - S401